82 related articles for article (PubMed ID: 3257991)
1. Recombinant murine IL-3 fails to stimulate T or B lymphopoiesis in vivo, but enhances immune responses to T cell-dependent antigens.
Kimoto M; Kindler V; Higaki M; Ody C; Izui S; Vassalli P
J Immunol; 1988 Mar; 140(6):1889-94. PubMed ID: 3257991
[TBL] [Abstract][Full Text] [Related]
2. IL-1 inhibits B cell differentiation in long term bone marrow cultures.
Dorshkind K
J Immunol; 1988 Jul; 141(2):531-8. PubMed ID: 3260256
[TBL] [Abstract][Full Text] [Related]
3. Administration of recombinant interleukin 2 to mice enhances production of hemopoietic and natural killer cells.
Piguet PF; Grau G; Irle C; Vassalli P
Eur J Immunol; 1986 Oct; 16(10):1257-61. PubMed ID: 3490387
[TBL] [Abstract][Full Text] [Related]
4. Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases.
Komschlies KL; Gregorio TA; Gruys ME; Back TC; Faltynek CR; Wiltrout RH
J Immunol; 1994 Jun; 152(12):5776-84. PubMed ID: 8207207
[TBL] [Abstract][Full Text] [Related]
5. Modulation of early B lymphopoiesis by interleukin-3.
Ball TC; Hirayama F; Ogawa M
Exp Hematol; 1996 Aug; 24(10):1225-31. PubMed ID: 8765498
[TBL] [Abstract][Full Text] [Related]
6. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.
Funakoshi S; Taub DD; Anver MR; Raziuddin A; Asai O; Reddy V; Rager H; Fanslow WC; Longo DL; Murphy WJ
J Clin Invest; 1997 Feb; 99(3):484-91. PubMed ID: 9022082
[TBL] [Abstract][Full Text] [Related]
7. In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation.
Jardieu P; Clark R; Mortensen D; Dorshkind K
J Immunol; 1994 May; 152(9):4320-7. PubMed ID: 8157955
[TBL] [Abstract][Full Text] [Related]
8. IL-10 inhibits IL-7-mediated murine pre-B cell growth in vitro.
Elia JM; Hamilton BL; Riley RL
Exp Hematol; 1995 Apr; 23(4):323-7. PubMed ID: 7534712
[TBL] [Abstract][Full Text] [Related]
9. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen.
Hough MR; Chappel MS; Sauvageau G; Takei F; Kay R; Humphries RK
J Immunol; 1996 Jan; 156(2):479-88. PubMed ID: 8543797
[TBL] [Abstract][Full Text] [Related]
10. IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and precursor B cell dynamics.
Fauteux LJ; Osmond DG
J Immunol; 1996 Apr; 156(7):2376-83. PubMed ID: 8786294
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
[TBL] [Abstract][Full Text] [Related]
12. Influence of IL-10 on murine CFU-pre-B formation.
Fine JS; Macosko HD; Grace MJ; Narula SK
Exp Hematol; 1994 Nov; 22(12):1188-96. PubMed ID: 7925782
[TBL] [Abstract][Full Text] [Related]
13. Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.
O'Neill HC; Ni K
Immunology; 1993 Jun; 79(2):220-8. PubMed ID: 8344701
[TBL] [Abstract][Full Text] [Related]
14. Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 origin.
Reimann J; Bellan A; Kabelitz D
J Immunol; 1987 Feb; 138(4):1042-50. PubMed ID: 3492539
[TBL] [Abstract][Full Text] [Related]
15. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells.
Beagley KW; Eldridge JH; Kiyono H; Everson MP; Koopman WJ; Honjo T; McGhee JR
J Immunol; 1988 Sep; 141(6):2035-42. PubMed ID: 3262647
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine-like activity of 8-mercaptoguanosine: induction of T and B cell differentiation.
Feldbush TL; Ballas ZK
J Immunol; 1985 May; 134(5):3204-11. PubMed ID: 3872330
[TBL] [Abstract][Full Text] [Related]
17. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
[TBL] [Abstract][Full Text] [Related]
18. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
19. Antigens displayed on murine B lymphocyte precursors.
Kincade PW; Lee G; Watanabe T; Sun L; Scheid MP
J Immunol; 1981 Dec; 127(6):2262-8. PubMed ID: 6975314
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-1 stimulation of lymphopoiesis.
Clark R; Strasser J; McCabe S; Robbins K; Jardieu P
J Clin Invest; 1993 Aug; 92(2):540-8. PubMed ID: 8349796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
